Drug Type Mesenchymal stem cell therapy |
Synonyms Human umbilical cord tissue-derived mesenchymal stem cells (Bright Cell, Inc.), YB 1113, YB1113 |
Target- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Menopause, Premature | Phase 1 | - | 09 Jan 2025 |